Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,265 | -2,440 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 47 | -52 | N/A | N/A | N/A |
| Other Working Capital | -118 | 18 | N/A | N/A | N/A |
| Other Operating Activity | 1,205 | 800 | 0 | 0 | 0 |
| Operating Cash Flow | $-2,131 | $-1,674 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,602 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $4,602 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 2,599 | 4,273 | N/A | N/A | N/A |
| End Cash Position | 5,069 | 2,599 | N/A | N/A | N/A |
| Net Cash Flow | $2,470 | $-1,674 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,131 | -1,674 | N/A | N/A | N/A |
| Free Cash Flow | -2,131 | -1,674 | 0 | 0 | 0 |